Quality Review
Meet the Q&PS Team
MedicASK Answers
MedicASK Answers Full List
Patient Safety Incident Report
Loss or theft of controlled substances
MedicASK
Files
Analgesia Topup
Question# 1001
If a patient has taken, for example, 325 mg of Tylenol one hour ago and is still complaining of pain, our current medical directive lists acetaminophen use within the previous 4 hours as a contraindication.
Does this mean that, even though the patient has only taken approximately one-third of the dose we would normally administer, we are unable to give an additional dose to reach the usual adult dose of 960–1,000 mg?
Does this mean that, even though the patient has only taken approximately one-third of the dose we would normally administer, we are unable to give an additional dose to reach the usual adult dose of 960–1,000 mg?
Answer:
From a pharmacologic, patient safety, and analgesic effectiveness perspective, administering an additional dose of acetaminophen to bring the patient's total dose to approximately 975–1,000 mg within four hours of an initial 325 mg dose is considered a reasonable intervention, provided the patient continues to require analgesia and otherwise meets the applicable criteria of the ALS PCS. This is good patient care.
Although the current medical directive identifies acetaminophen use within the previous four hours as a contraindication, this scenario involves supplementing a subtherapeutic dose rather than administering a full repeat dose. In these circumstances, providing a supplemental dose to achieve the standard adult therapeutic dose is considered clinically appropriate.
As this approach is not explicitly reflected in the current ALS PCS dosing language, thorough documentation should be completed outlining the patient's prior acetaminophen use, the clinical rationale for administering the supplemental dose, and the total dose provided. The timing of all acetaminophen administration should also be communicated to the receiving facility, as it may influence subsequent analgesic dosing decisions.
Although the current medical directive identifies acetaminophen use within the previous four hours as a contraindication, this scenario involves supplementing a subtherapeutic dose rather than administering a full repeat dose. In these circumstances, providing a supplemental dose to achieve the standard adult therapeutic dose is considered clinically appropriate.
As this approach is not explicitly reflected in the current ALS PCS dosing language, thorough documentation should be completed outlining the patient's prior acetaminophen use, the clinical rationale for administering the supplemental dose, and the total dose provided. The timing of all acetaminophen administration should also be communicated to the receiving facility, as it may influence subsequent analgesic dosing decisions.